PTGX announcements Protagonist Therapeutics, Inc. announcements and dividends declared NASDAQ

Protagonist Therapeutics, Inc. Complete list of announcements declared & dividend announcements by Protagonist Therapeutics, Inc. PTGX

Protagonist Therapeutics, Inc. PTGX listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Protagonist Therapeutics, Inc. PTGX

Piper Sandler Reiterates Protagonist Therapeutics (PTGX) Overweight Recommendation
Fintel reports that on July 3, 2023, Piper Sandler reiterated coverage of Protagonist Therapeutics (NASDAQ:PTGX) with a Overweight recommendation.
Announcement as on 04 July 2023

BTIG Reiterates Protagonist Therapeutics (PTGX) Buy Recommendation
Fintel reports that on July 3, 2023, BTIG reiterated coverage of Protagonist Therapeutics (NASDAQ:PTGX) with a Buy recommendation.
Announcement as on 04 July 2023

Why Shares of Protagonist Therapeutics Rose This Week
What happened Shares of Protagonist Therapeutics (NASDAQ: PTGX) rose by 23.3% for the week, as of Thursday afternoon, according to data provided by S&P Global Market Intelligence. The clinical-stage biotech company's stock closed last week at .74 and ro
Announcement as on 21 April 2023

Biotechnology Value Fund L P Now Owns 9.60% of Protagonist Therapeutics (PTGX)
Fintel reports that Biotechnology Value Fund L P has filed a 13G form with the SEC disclosing ownership of 5.03MM shares of Protagonist Therapeutics Inc (PTGX). This represents 9.6% of the company.
Announcement as on 20 March 2023

Protagonist Therapeutics shares slid after sharing Phase 2 data for its experimental ulcerative colitis treatment
Shares of Protagonist Therapeutics Inc. tumbled 30.8% in premarket trading on Tuesday the day after the company said a Phase 2 clinical trial that gave patients a higher dose of its experimental ulcerative colitis treatment did not meet the primary endpoi
Announcement as on 26 April 2022

Announcements by Protagonist Therapeutics, Inc. first page | Next page |

PTGX Protagonist Therapeutics, Inc. current price & indicator signals

Moving Averages for Protagonist Therapeutics, Inc.

  • 5Day Average: 37.95
  • 12Day Average: 38.05
  • 20Day Average: 37.92
  • 50Day Average: 38.7
  • 100Day Average: 41.97
  • 150Day Average: 41.44
  • 200Day Average: 38.91

PTGX Indicators & signals

Indicator MACD (12,26,9)

38.05, 38.16, -0.27
Indicator MACD is in negative zone

Indicator ADX (14)

13.43, 24.52, 18.71
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of PTGX Protagonist Therapeutics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
14 Fri Feb 2025 38.67 38.36 to 39.37 -0.03% 0.63 times
13 Thu Feb 2025 38.68 37.38 to 38.72 3.37% 0.64 times
12 Wed Feb 2025 37.42 36.34 to 37.54 1.16% 0.72 times
11 Tue Feb 2025 36.99 36.70 to 38.01 -2.63% 1.56 times
10 Mon Feb 2025 37.99 37.74 to 39.52 -2.29% 1.21 times
07 Fri Feb 2025 38.88 37.81 to 39.66 2.99% 1.3 times
06 Thu Feb 2025 37.75 37.70 to 39.31 -2% 0.91 times
05 Wed Feb 2025 38.52 37.72 to 38.62 2.5% 0.95 times
04 Tue Feb 2025 37.58 37.06 to 38.32 1.02% 0.8 times
03 Mon Feb 2025 37.20 36.65 to 37.50 -1.59% 0.84 times
31 Fri Jan 2025 37.80 37.58 to 39.64 -3.37% 1.07 times
30 Thu Jan 2025 39.12 37.98 to 39.45 2.38% 0.57 times

Videos related to: PTGX announcements Protagonist Therapeutics, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

PTGX announcements Protagonist Therapeutics, Inc. announcements and dividends declared NASDAQ

 

Back to top